Depression is a common and one of the most affected mental diseases. According to WHO, worldwide, more than 264 million people are depressed or affected by this. Schizophrenia is another condition that affects the emotions and thoughts of the patient. The biggest issue with mental illness that the patients take much time to accept. Hence the disease gets older, and its treatment becomes longer. First-generation drugs help the patients, but they also have some side effects like lack of sleep, anxiety, weight gain, etc. Now many biotechnology companies are working to develop the next generation of medicine to cure mental illness, and Bright Minds is one of them.